Viread is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Tenofovir Disoproxil Fumarate.
| Product ID | 61958-0401_741e31d6-533d-4da5-8a00-364d657ee3ab |
| NDC | 61958-0401 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Viread |
| Generic Name | Tenofovir Disoproxil Fumarate |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2001-10-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021356 |
| Labeler Name | Gilead Sciences, Inc. |
| Substance Name | TENOFOVIR DISOPROXIL FUMARATE |
| Active Ingredient Strength | 300 mg/1 |
| Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2001-10-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021356 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2001-10-26 |
| Ingredient | Strength |
|---|---|
| TENOFOVIR DISOPROXIL FUMARATE | 300 mg/1 |
| SPL SET ID: | 33fd6418-fbdc-42ca-a50d-ce2a476a5418 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-0754 | Viread | TENOFOVIR DISOPROXIL FUMARATE |
| 53808-0810 | Viread | tenofovir disoproxil fumarate |
| 61958-0401 | Viread | TENOFOVIR DISOPROXIL FUMARATE |
| 61958-0403 | Viread | TENOFOVIR DISOPROXIL FUMARATE |
| 61958-0404 | Viread | TENOFOVIR DISOPROXIL FUMARATE |
| 61958-0405 | Viread | TENOFOVIR DISOPROXIL FUMARATE |
| 61958-0406 | Viread | TENOFOVIR DISOPROXIL FUMARATE |
| 69189-0401 | Viread | Viread |
| 70518-0546 | Viread | Viread |
| 0093-7104 | Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
| 16714-820 | Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
| 31722-535 | Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
| 42291-800 | Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
| 42385-901 | Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
| 50268-758 | TENOFOVIR DISOPROXIL FUMARATE | tenofovir disoproxil fumarate |
| 53808-1128 | TENOFOVIR DISOPROXIL FUMARATE | tenofovir disoproxil fumarate |
| 60505-4666 | Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
| 60687-366 | Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
| 64380-714 | TENOFOVIR DISOPROXIL FUMARATE | tenofovir disoproxil fumarate |
| 65862-421 | Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
| 65862-818 | Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VIREAD 76079330 2586295 Live/Registered |
Gilead Sciences, Inc. 2000-06-28 |